Tag Archives: GAAP vs. Non-GAAP
An Update on Merck (MRK)
Product Pipeline Successes. Merck has enjoyed a couple of notable successes in its product pipeline over the past year. The first and most important is Keytruda (pembrolizumab), the company’s anti-PD-1 (programmed death receptor-1) immunotherapy treatment for cancer. Keytruda has already … Continue reading
Posted in Health Care, MRK
Tagged Accounting, GAAP vs. Non-GAAP
Comments Off on An Update on Merck (MRK)